Michael J. Fox Foundation for Parkinson’s Research Seeks Applications for Cognition Biomarker Research Projects

The Michael J. Fox Foundation for Parkinson’s Research is accepting pre-proposals for projects aimed at developing biomarkers of cognitive impairment in Parkinson’s disease.

Grants totaling $3 million will be awarded to support projects that aim to develop cognition biomarkers or combinations of biomarkers that help identify the transitions between normal cognition and cognitive impairment, and between cognitive impairment and dementia. Appropriate projects include, but are not limited to, data analyses in clinically well-characterized PD populations to correlate defined biological and clinical features with cognitive decline, hypothesis-driven imaging studies for identification of changes associated with different patterns of cognitive decline and transitions between different cognitive states, studies that seek to define predictive or state-defining biomarkers associated with specific cognitive profiles, and studies that seek to evaluate the predictive value of combinations of two or more biomarkers.

Eligible applicants include biotechnology/pharmaceutical companies, other for-profit entities public and private nonprofit universities, colleges, hospitals, laboratories, and government agencies.

Pre-proposals must be received no later than June 19, 2013. Upon review, selected applicants will be invited to submit full proposals by July 3, 2013.

More information at: